FRIDAY, Nov. 15, 2024 (HealthDay News) — An experimental vaccine has shown promise in protecting against the sexually transmitted disease chlamydia, researchers report. Lab mice given the vaccine were able to rapidly clear subsequent chlamydia infections, and were less likely to develop severe infections compared with unvaccinated mice, researchers reportedContinue Reading

WEDNESDAY, Nov. 13, 2024 (HealthDay News) — The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain toContinue Reading

WEDNESDAY, Nov. 13, 2024 (HealthDay News) — People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns. Patients who land in the ER following hallucinogen use have a 21-fold higher risk of developing schizophrenia compared to the general population, Canadian researchers report. EvenContinue Reading